Press Releases
-
Synap Biotech Inc.™ Appoints Dr. Pallavi Tawde as Chief Scientific Officer and Co-Founder
Norfolk, VA — October 29, 2025 — Synap Biotech Inc™., a biotechnology company pioneering intranasal Nanobody® based therapies for neurological recovery, is pleased to announce the appointment of Dr. Pallavi Tawde as Chief Scientific Officer and Co-Founder.
-
Synap Biotech Inc.™ Appoints Professor Serge Muyldermans to Its Scientific Advisory Board
Norfolk, VA — December 2, 2025 — Synap Biotech, Inc.™, a biotechnology company pioneering intranasal Nanobody®-based therapies to unlock brain repair, is pleased to announce that Prof. Serge Muyldermans, the original pioneer of Nanobody® technology and co-founder of Ablynx N.V., has joined the company’s Scientific Advisory Board (SAB).
-
Synap Biotech Inc.™ Appoints Brent Buchine, PhD to its Board of Directors
Norfolk, VA — January 6, 2026 — Synap Biotech, Inc.™, a biotechnology company pioneering intranasal Nanobody®-based therapies to unlock brain repair, today announced the appointment of Brent A. Buchine, Ph.D. to its Board of Directors.